JustInvest LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 33.0% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 15,470 shares of the healthcare conglomerate’s stock after buying an additional 3,836 shares during the quarter. UnitedHealth Group makes up about 0.9% of JustInvest LLC’s holdings, making the stock its 14th biggest position. JustInvest LLC’s holdings in UnitedHealth Group were worth $5,756,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in UNH. Accel Wealth Management purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $26,000. Atlas Private Wealth Advisors increased its stake in shares of UnitedHealth Group by 46.2% during the 1st quarter. Atlas Private Wealth Advisors now owns 95 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 30 shares during the last quarter. Sage Private Wealth Group LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth $36,000. IronBridge Private Wealth LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth $37,000. Finally, Costello Asset Management INC increased its stake in shares of UnitedHealth Group by 500.0% during the 4th quarter. Costello Asset Management INC now owns 120 shares of the healthcare conglomerate’s stock worth $42,000 after purchasing an additional 100 shares during the last quarter. Institutional investors own 86.03% of the company’s stock.

UNH has been the topic of several analyst reports. Truist Securities increased their price target on shares of UnitedHealth Group from $420.00 to $450.00 and gave the stock a “buy” rating in a research note on Tuesday, April 20th. Credit Suisse Group raised their target price on shares of UnitedHealth Group from $415.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, April 22nd. Mizuho raised their target price on shares of UnitedHealth Group from $380.00 to $394.00 and gave the company a “buy” rating in a research note on Thursday, April 15th. Truist raised their target price on shares of UnitedHealth Group from $420.00 to $450.00 in a research note on Wednesday, April 14th. Finally, BMO Capital Markets raised their target price on shares of UnitedHealth Group from $410.00 to $435.00 and gave the company a “market perform” rating in a research note on Thursday, April 22nd. Three research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $409.61.

NYSE UNH traded up $1.10 during trading hours on Tuesday, reaching $407.00. 35,547 shares of the company’s stock were exchanged, compared to its average volume of 3,262,127. The stock has a market cap of $384.16 billion, a PE ratio of 23.31, a price-to-earnings-growth ratio of 1.55 and a beta of 0.74. UnitedHealth Group Incorporated has a one year low of $273.71 and a one year high of $406.77. The firm has a fifty day moving average of $378.48 and a 200-day moving average of $349.25. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.59.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Wednesday, April 14th. The healthcare conglomerate reported $5.31 EPS for the quarter, beating the Zacks’ consensus estimate of $4.38 by $0.93. The firm had revenue of $70.20 billion for the quarter, compared to analyst estimates of $69.13 billion. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The business’s quarterly revenue was up 9.0% compared to the same quarter last year. During the same period last year, the company earned $3.72 EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 16.75 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 23rd. Shareholders of record on Monday, March 15th were given a $1.25 dividend. The ex-dividend date of this dividend was Friday, March 12th. This represents a $5.00 dividend on an annualized basis and a yield of 1.23%. UnitedHealth Group’s payout ratio is 33.09%.

In related news, CAO Thomas E. Roos sold 5,301 shares of the firm’s stock in a transaction on Tuesday, April 27th. The stock was sold at an average price of $394.66, for a total transaction of $2,092,092.66. Following the sale, the chief accounting officer now owns 58,589 shares of the company’s stock, valued at approximately $23,122,734.74. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Thomas E. Roos sold 619 shares of the firm’s stock in a transaction on Tuesday, February 9th. The stock was sold at an average price of $323.90, for a total value of $200,494.10. Following the sale, the chief accounting officer now directly owns 31,908 shares in the company, valued at approximately $10,335,001.20. The disclosure for this sale can be found here. Insiders sold a total of 20,420 shares of company stock worth $7,532,962 over the last quarter. Corporate insiders own 0.80% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.

Featured Story: Conference Calls and Individual Investors

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.